08:00 , Dec 18, 2000 |  BC Week In Review  |  Company News

PPL, Celentis deal

PTH entered into a 50-50 joint venture with Celentis, the commercial arm of AgResearch, a New Zealand government research institute. The companies will produce pharmaceutical and nutraceutical proteins in the milk of transgenic cattle, initially...
08:00 , Dec 18, 2000 |  BioCentury  |  Finance

Meltdown

After suffering a regulatory and investor thrashing that knocked 70 percent off the company's value last week, Maxim's market cap of $185.9 million now stands below the $190.4 million in cash it had on the...
08:00 , Dec 14, 2000 |  BC Extra  |  Company News

PTH and Celentis in cloning venture

PPL Therapeutics (LSE:PTH) entered into a joint venture with Celentis ( Hamilton , New Zealand ), the commercial arm of AgResearch, a New Zealand government research institute. The companies will focus on producing pharmaceutical and...